Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
386K
-
Shares change
-
+4.23K
-
Total reported value, excl. options
-
$5.65M
-
Value change
-
+$61.7K
-
Number of buys
-
7
-
Number of sells
-
-6
-
Price
-
$14.64
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q3 2025
22 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q3 2025.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 386K shares
.
Largest 10 shareholders include Legacy Wealth Asset Management, LLC (166K shares), Investors Research Corp (44.5K shares), YOUSIF CAPITAL MANAGEMENT, LLC (32.4K shares), Lester Murray Antman dba SimplyRich (32.1K shares), Aaron Wealth Advisors LLC (30.6K shares), BARTLETT & CO. WEALTH MANAGEMENT LLC (25.3K shares), Vontobel Holding Ltd. (17.6K shares), NATURAL INVESTMENTS, LLC (13.2K shares), U.S. Capital Wealth Advisors, LLC (13K shares), and Optas, LLC (11.3K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.